| Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin C Garcia-Rodriguez, IN Geren, J Lou, F Conrad, C Forsyth, W Wen, ... Protein engineering, design & selection 24 (3), 321-331, 2011 | 81 | 2011 |
| A multiplexed, automated evolution pipeline enables scalable discovery and characterization of biosensors B Townshend, JS Xiang, G Manzanarez, EJ Hayden, CD Smolke Nature communications 12 (1), 1437, 2021 | 42 | 2021 |
| Cellular perception of growth rate and the mechanistic origin of bacterial growth law C Wu, R Balakrishnan, N Braniff, M Mori, G Manzanarez, Z Zhang, T Hwa Proceedings of the National Academy of Sciences 119 (20), e2201585119, 2022 | 39 | 2022 |
| Engineered domain-based assays to identify individual antibodies in oligoclonal combinations targeting the same protein Q Meng, C Garcia-Rodriguez, G Manzanarez, MA Silberg, F Conrad, ... Analytical biochemistry 430 (2), 141-150, 2012 | 36 | 2012 |
| INAUGURAL ARTICLE by a Recently Elected Academy Member: Cellular perception of growth rate and the mechanistic origin of bacterial growth law C Wu, R Balakrishnan, N Braniff, M Mori, G Manzanarez, Z Zhang, T Hwa Proceedings of the National Academy of Sciences of the United States of …, 2022 | | 2022 |
| 131. Human antibody engineering for prevention and treatment of botulinum neurotoxin (BoNT) intoxication J Lou, C Garcia-Rodriguez, Y Fan, J Dong, W Wen, F Conrad, ... Toxicon, S40-S41, 2015 | | 2015 |
| Generation, expression and purification of monoclonal-antibody-specific engineered domains to support development of oligoclonal recombinant antitoxins against BoNT/B and BoNT/E Q Meng, C Garcia, M Silberg, G Manzanarez, J Lou, Y Fan, F Conrad, ... Toxicon, 90, 2013 | | 2013 |
